These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27164080)

  • 21. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases.
    Shi Y; Wang Y; Li Q; Liu K; Hou J; Shao C; Wang Y
    Nat Rev Nephrol; 2018 Aug; 14(8):493-507. PubMed ID: 29895977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model.
    Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F
    Front Immunol; 2019; 10():619. PubMed ID: 31001253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease.
    Kim Y; Jin HJ; Heo J; Ju H; Lee HY; Kim S; Lee S; Lim J; Jeong SY; Kwon J; Kim M; Choi SJ; Oh W; Yang YS; Hwang HH; Yu HY; Ryu CM; Jeon HB; Shin DM
    Leukemia; 2018 Dec; 32(12):2672-2684. PubMed ID: 29789652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
    Introna M; Golay J
    Front Immunol; 2020; 11():609063. PubMed ID: 33362797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.
    Huang Y; Wu Q; Tam PKH
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cells as immunomodulator therapies for immune-mediated systemic dermatoses.
    Reddy BY; Xu DS; Hantash BM
    Stem Cells Dev; 2012 Feb; 21(3):352-62. PubMed ID: 21864110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct Immunoregulatory Mechanisms in Mesenchymal Stem Cells: Role of the Cytokine Environment.
    Holan V; Hermankova B; Bohacova P; Kossl J; Chudickova M; Hajkova M; Krulova M; Zajicova A; Javorkova E
    Stem Cell Rev Rep; 2016 Dec; 12(6):654-663. PubMed ID: 27665290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.
    Lee HK; Kim HS; Pyo M; Park EJ; Jang S; Jun HW; Lee TY; Kim KS; Bae SC; Kim Y; Hong JT; Yun J; Han SB
    Theranostics; 2020; 10(22):10186-10199. PubMed ID: 32929342
    [No Abstract]   [Full Text] [Related]  

  • 29. MiR-153-3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord-derived mesenchymal stem cells in patients with systemic lupus erythematosus.
    Li D; Li X; Duan M; Dou Y; Feng Y; Nan N; Zhang W
    Autoimmunity; 2020 Jun; 53(4):201-209. PubMed ID: 32321315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions.
    Bassani B; Tripodo C; Portararo P; Gulino A; Botti L; Chiodoni C; Jachetti E; Bolli N; Ciciarello M; Joehrens K; Anagnostopoulos I; Na IK; Curti A; Colombo MP; Sangaletti S
    Front Immunol; 2021; 12():662048. PubMed ID: 34084166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCL2 expression.
    Che N; Li X; Zhang L; Liu R; Chen H; Gao X; Shi S; Chen W; Sun L
    J Immunol; 2014 Nov; 193(10):5306-14. PubMed ID: 25339674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential efficacy of human mesenchymal stem cells based on source of origin.
    Collins E; Gu F; Qi M; Molano I; Ruiz P; Sun L; Gilkeson GS
    J Immunol; 2014 Nov; 193(9):4381-90. PubMed ID: 25274529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation.
    Kim EJ; Kim N; Cho SG
    Exp Mol Med; 2013 Jan; 45(1):e2. PubMed ID: 23306700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation.
    Min CK; Kim BG; Park G; Cho B; Oh IH
    Bone Marrow Transplant; 2007 May; 39(10):637-45. PubMed ID: 17369865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs.
    Girdlestone J; Pido-Lopez J; Srivastava S; Chai J; Leaver N; Galleu A; Lombardi G; Navarrete CV
    Cytotherapy; 2015 Sep; 17(9):1188-99. PubMed ID: 26276002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus.
    Geng L; Tang X; Wang S; Sun Y; Wang D; Tsao BP; Feng X; Sun L
    Front Immunol; 2020; 11():233. PubMed ID: 32133007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mesenchymal stem cell therapy in hematopoietic stem cell transplantation].
    Goto T; Murata M
    Rinsho Ketsueki; 2018; 59(2):195-204. PubMed ID: 29515075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.
    Pontikoglou C; Kastrinaki MC; Klaus M; Kalpadakis C; Katonis P; Alpantaki K; Pangalis GA; Papadaki HA
    Stem Cells Dev; 2013 May; 22(9):1329-41. PubMed ID: 23249221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.